To test the role of LINC01419 in doxorubicin resistance, we treated the Huh7 cell line with doxorubicin and observed obvious increase in the DNA damage in the LINC01419 knockdown HCC cells (Figure 4(b)). Here, LINC01419 is linked to hepatocellular carcinoma.